{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:41:35Z","timestamp":1792802495331,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01846-3","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T14:51:51Z","timestamp":1753195911000},"page":"5011-5021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF\u0138B, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Koleshwar","family":"Mahto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1796-4913","authenticated-orcid":false,"given":"Omkar Kumar","family":"Kuwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayushi","family":"Maloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nileshwar","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"17","key":"1846_CR1","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.3390\/ijms22179583","volume":"22","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Jo MH, Ikram M, Khan A, Kim MO (2021) Deciphering the potential neuroprotective effects of luteolin against A\u03b21\u201342-Induced alzheimer\u2019s disease. Int J Mol Sci 22(17):9583","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1846_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archneur.64.2.185","volume":"64","author":"O Aktas","year":"2007","unstructured":"Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F (2007) Neuronal damage in brain inflammation. Arch Neurol 64(2):185\u2013189","journal-title":"Arch Neurol"},{"issue":"4","key":"1846_CR3","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s11033-020-05346-1","volume":"47","author":"AJA Albarakati","year":"2020","unstructured":"Albarakati AJA, Baty RS, Aljoudi AM, Habotta OA, Elmahallawy EK, Kassab RB, Abdel Moneim AE (2020) Luteolin protects against lead acetate-induced nephrotoxicity through antioxidant, anti-inflammatory, anti-apoptotic, and Nrf2\/HO-1 signaling pathways. Mol Biol Rep 47(4):2591\u20132603","journal-title":"Mol Biol Rep"},{"issue":"2","key":"1846_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jdad2020017","volume":"2","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Alkhalifa O, Durdanovic I, Ibrahim DR, Maragkou S (2025) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease: Insights into pathophysiology and treatment. J Dementia Alzheimer\u2019s Dis 2(2):17","journal-title":"J Dementia Alzheimer\u2019s Dis"},{"issue":"2","key":"1846_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"I Babkina","year":"2021","unstructured":"Babkina I, Sergeeva S, Gorbacheva L (2021) The role of NF-\u03baB in neuroinflammation. Neurochem J 15(2):114\u2013128","journal-title":"Neurochem J"},{"issue":"3","key":"1846_CR6","first-page":"199","volume":"1","author":"AD Bachstetter","year":"2010","unstructured":"Bachstetter AD, Van Eldik LJ (2010) The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS. Aging Dis 1(3):199","journal-title":"Aging Dis"},{"key":"1846_CR7","doi-asserted-by":"crossref","unstructured":"Badhe RV, Chejara DR, Kumar P, Choonara YE, Pillay V (2018) Neurodegenerative disease conditions and genomic treatment for better health. Genomics-driven healthcare: Trends in disease prevention and treatment 281\u2013310","DOI":"10.1007\/978-981-10-7506-3_15"},{"key":"1846_CR8","unstructured":"Bankell E (2024) From inflammation to apoptosis with focus on non-classical immune cells"},{"issue":"6","key":"1846_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/biom10060863","volume":"10","author":"MA Bhat","year":"2020","unstructured":"Bhat MA, Ahmad K, Khan MSA, Bhat MA, Almatroudi A, Rahman S, Jan AT (2020) Expedition into taurine biology: structural insights and therapeutic perspective of taurine in neurodegenerative diseases. Biomolecules 10(6):863","journal-title":"Biomolecules"},{"key":"1846_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00479-8","volume":"16","author":"S Bono","year":"2021","unstructured":"Bono S, Feligioni M, Corbo M (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Mol Neurodegener 16:1\u201326","journal-title":"Mol Neurodegener"},{"issue":"24","key":"1846_CR11","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1080\/10408398.2021.1905604","volume":"62","author":"K Borowiec","year":"2022","unstructured":"Borowiec K, Michalak A (2022) Flavonoids from edible fruits as therapeutic agents in neuroinflammation\u2013a comprehensive review and update. Crit Rev Food Sci Nutr 62(24):6742\u20136760","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"1846_CR12","first-page":"376","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases\u2606. Neural Regen Res 7(5):376\u2013385","journal-title":"Neural Regen Res"},{"issue":"6","key":"1846_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.numecd.2020.02.014","volume":"30","author":"H-I Chen","year":"2020","unstructured":"Chen H-I, Hu W-S, Hung M-Y, Ou H-C, Huang S-H, Hsu P-T, Day C-H, Lin K-H, Viswanadha VP, Kuo W-W (2020) Protective effects of luteolin against oxidative stress and mitochondrial dysfunction in endothelial cells. Nutr Metab Cardiovasc Dis 30(6):1032\u20131043","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"1846_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/biomedicines11040999","volume":"11","author":"A Chiarini","year":"2023","unstructured":"Chiarini A, Gui L, Viviani C, Armato U, Dal Pr\u00e0 I (2023) NLRP3 inflammasome\u2019s activation in acute and chronic brain diseases\u2014an update on pathogenetic mechanisms and therapeutic perspectives with respect to other inflammasomes. Biomedicines 11(4):999","journal-title":"Biomedicines"},{"issue":"5","key":"1846_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-025-04267-9","volume":"15","author":"S Chib","year":"2025","unstructured":"Chib S, Dutta BJ, Singh G, Singh R, Singh S (2025) Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson\u2019s disease. 3 Biotech 15(5):1\u201312","journal-title":"3 Biotech"},{"issue":"1\u20132","key":"1846_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2011.06.047","volume":"668","author":"AY Choi","year":"2011","unstructured":"Choi AY, Choi JH, Yoon H, Hwang K-Y, Noh MH, Choe W, Yoon K-S, Ha J, Yeo E-J, Kang I (2011) Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells. Eur J Pharmacol 668(1\u20132):115\u2013126","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"1846_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/molecules21101312","volume":"21","author":"S Cirmi","year":"2016","unstructured":"Cirmi S, Ferlazzo N, Lombardo GE, Ventura-Spagnolo E, Gangemi S, Calapai G, Navarra M (2016) Neurodegenerative diseases: might citrus flavonoids play a protective role? Molecules 21(10):1312","journal-title":"Molecules"},{"issue":"13","key":"1846_CR18","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.3390\/ijms241310809","volume":"24","author":"AV Ciurea","year":"2023","unstructured":"Ciurea AV, Mohan AG, Covache-Busuioc R-A, Costin H-P, Glavan L-A, Corlatescu A-D, Saceleanu VM (2023) Unraveling molecular and genetic insights into neurodegenerative diseases: Advances in understanding Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s diseases and amyotrophic lateral sclerosis. Int J Mol Sci 24(13):10809","journal-title":"Int J Mol Sci"},{"key":"1846_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","volume":"9","author":"P Deshmukh","year":"2017","unstructured":"Deshmukh P, Unni S, Krishnappa G, Padmanabhan B (2017) The Keap1\u2013Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys Rev 9:41\u201356","journal-title":"Biophys Rev"},{"key":"1846_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-3","volume":"7","author":"K Dirscherl","year":"2010","unstructured":"Dirscherl K, Karlstetter M, Ebert S, Kraus D, Hlawatsch J, Walczak Y, Moehle C, Fuchshofer R, Langmann T (2010) Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflamm 7:1\u201316","journal-title":"J Neuroinflamm"},{"key":"1846_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-001-0481-9","volume":"103","author":"I Ferrer","year":"2002","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Dominguez I, Vinals F (2002) Active, phosphorylation-dependent MAP kinases, MAPK\/ERK, SAPK\/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat. Acta Neuropathol 103:391\u2013407","journal-title":"Acta Neuropathol"},{"key":"1846_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00401-002-0661-2","volume":"105","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, Friguls B, Dalf\u00f3 E, Planas AM (2003) Early modifications in the expression of mitogen-activated protein kinase (MAPK\/ERK), stress-activated kinases SAPK\/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia. Acta Neuropathol 105:425\u2013437","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1846_CR23","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"LB Haim","year":"2015","unstructured":"Haim LB, Ceyz\u00e9riat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E (2015) The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases. J Neurosci 35(6):2817\u20132829","journal-title":"J Neurosci"},{"key":"1846_CR24","unstructured":"Hasim MS (2012) Molecular mechanisms of MMP9 expression in astrocytes induced by heme and iron. University of Ottawa (Canada)"},{"issue":"13","key":"1846_CR25","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21(13):4777","journal-title":"Int J Mol Sci"},{"issue":"1\u20134","key":"1846_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10799899909036638","volume":"19","author":"MH Heim","year":"1999","unstructured":"Heim MH (1999) The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Recept Sign Trans 19(1\u20134):75\u2013120","journal-title":"J Recept Sign Trans"},{"issue":"5","key":"1846_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097880","volume":"9","author":"L-W Hu","year":"2014","unstructured":"Hu L-W, Yen J-H, Shen Y-T, Wu K-Y, Wu M-J (2014) Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells. PLoS One 9(5):e97880","journal-title":"PLoS One"},{"key":"1846_CR28","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X (2022) The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol 12:1023177","journal-title":"Front Oncol"},{"key":"1846_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.arr.2014.07.002","volume":"18","author":"JM Hyttinen","year":"2014","unstructured":"Hyttinen JM, Amadio M, Viiri J, Pascale A, Salminen A, Kaarniranta K (2014) Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases. Ageing Res Rev 18:16\u201328","journal-title":"Ageing Res Rev"},{"issue":"3\u20134","key":"1846_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/09727531211070532","volume":"28","author":"M Jain","year":"2021","unstructured":"Jain M, Singh MK, Shyam H, Mishra A, Kumar S, Kumar A, Kushwaha J (2021) Role of JAK\/STAT in the neuroinflammation and its association with neurological disorders. Ann Neurosci 28(3\u20134):191\u2013200","journal-title":"Ann Neurosci"},{"issue":"10","key":"1846_CR31","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.freeradbiomed.2004.02.074","volume":"36","author":"AK Jaiswal","year":"2004","unstructured":"Jaiswal AK (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biol Med 36(10):1199\u20131207","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"1846_CR32","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbrc.2005.04.057","volume":"331","author":"J-H Jang","year":"2005","unstructured":"Jang J-H, Surh Y-J (2005) AP-1 mediates \u03b2-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem Biophys Res Commun 331(4):1421\u20131428","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1846_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s43440-024-00610-8","volume":"76","author":"DK Jayawickreme","year":"2024","unstructured":"Jayawickreme DK, Ekwosi C, Anand A, Andres-Mach M, Wla\u017a P, Soca\u0142a K (2024) Luteolin for neurodegenerative diseases: a review. Pharmacol Rep 76(4):644\u2013664","journal-title":"Pharmacol Rep"},{"key":"1846_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuro.2022.03.004","volume":"90","author":"SS Josiah","year":"2022","unstructured":"Josiah SS, Famusiwa CD, Crown OO, Lawal AO, Olaleye MT, Akindahunsi AA, Akinmoladun AC (2022) Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1\u03b2, TNF-\u03b1, NF-\u03baB, I\u03baKB, and p53 genes in male Wistar rats. Neurotoxicology 90:158\u2013171","journal-title":"Neurotoxicology"},{"issue":"11","key":"1846_CR35","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u MC, Andronie-Cioara FL, Jurc\u0103u A, Marcu F, \u0162i\u021b DM, Pa\u0219cal\u0103u N, Nistor-Cseppent\u00f6 DC (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants 11(11):2167","journal-title":"Antioxidants"},{"key":"1846_CR36","doi-asserted-by":"crossref","unstructured":"Kaminska B (2005) MAPK signalling pathways as molecular targets for anti-inflammatory therapy\u2014from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta (BBA)-Proteins Proteom 1754(1\u20132):253\u2013262","DOI":"10.1016\/j.bbapap.2005.08.017"},{"issue":"2","key":"1846_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/biof.1687","volume":"47","author":"D Kempuraj","year":"2021","unstructured":"Kempuraj D, Thangavel R, Kempuraj DD, Ahmed ME, Selvakumar GP, Raikwar SP, Zaheer SA, Iyer SS, Govindarajan R, Chandrasekaran PN (2021) Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. BioFactors 47(2):190\u2013197","journal-title":"BioFactors"},{"key":"1846_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110154","volume":"88","author":"FO Kok","year":"2021","unstructured":"Kok FO, Wang H, Riedlova P, Goodyear CS, Carmody RJ (2021) Defining the structure of the NF-\u0138B pathway in human immune cells using quantitative proteomic data. Cell Signal 88:110154","journal-title":"Cell Signal"},{"issue":"1","key":"1846_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-025-00801-2","volume":"26","author":"OK Kunwar","year":"2025","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: Genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(1):1\u201315","journal-title":"Neurogenetics"},{"key":"1846_CR40","doi-asserted-by":"crossref","unstructured":"Kuwar OK, Kalia N (2025) Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF\u0138B in neurodegenerative disease. Inflammopharmacology 1\u20138","DOI":"10.1007\/s10787-025-01698-x"},{"issue":"1","key":"1846_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Trans Neurodegener 9(1):42","journal-title":"Trans Neurodegener"},{"key":"1846_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577758","volume":"361","author":"N-A Lashgari","year":"2021","unstructured":"Lashgari N-A, Roudsari NM, Momtaz S, Sathyapalan T, Abdolghaffari AH, Sahebkar A (2021) The involvement of JAK\/STAT signaling pathway in the treatment of Parkinson\u2019s disease. J Neuroimmunol 361:577758","journal-title":"J Neuroimmunol"},{"key":"1846_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114576","volume":"370","author":"JY Lee","year":"2023","unstructured":"Lee JY, Park CS, Seo KJ, Kim IY, Han S, Youn I, Yune TY (2023) IL-6\/JAK2\/STAT3 axis mediates neuropathic pain by regulating astrocyte and microglia activation after spinal cord injury. Exp Neurol 370:114576","journal-title":"Exp Neurol"},{"key":"1846_CR44","doi-asserted-by":"publisher","unstructured":"Kuwar OK, Singh S (2025) Baicalein-mediated regulation of Nrf2\/ARE, NF\u0138B, and MAPK signaling in Huntington\u2019s disease: a promising strategy against neuroinflammation and neurodegeneration. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01839-2","DOI":"10.1007\/s10787-025-01839-2"},{"issue":"15","key":"1846_CR45","doi-asserted-by":"publisher","first-page":"8458","DOI":"10.1021\/jf201637u","volume":"59","author":"TY Lin","year":"2011","unstructured":"Lin TY, Lu CW, Chang CC, Huang SK, Wang SJ (2011) Luteolin inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Agric Food Chem 59(15):8458\u20138466","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1846_CR46","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41598-017-08204-6","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Huang J, Zheng X, Yang X, Ding Y, Fang T, Zhang Y, Wang S, Zhang X, Luo X (2017) Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR\/4E-BP1 signaling pathway. Sci Rep 7(1):7877","journal-title":"Sci Rep"},{"issue":"6","key":"1846_CR47","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms22062805","volume":"22","author":"J Liu","year":"2021","unstructured":"Liu J, Ting JP, Al-Azzam S, Ding Y, Afshar S (2021) Therapeutic advances in diabetes, autoimmune, and neurological diseases. Int J Mol Sci 22(6):2805","journal-title":"Int J Mol Sci"},{"key":"1846_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113513","volume":"153","author":"P Liu","year":"2022","unstructured":"Liu P, Li Y, Wang W, Bai Y, Jia H, Yuan Z, Yang Z (2022) Role and mechanisms of the NF-\u0138B signaling pathway in various developmental processes. Biomed Pharmacother 153:113513","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1846_CR49","doi-asserted-by":"publisher","first-page":"6393872","DOI":"10.1155\/mi\/6393872","volume":"2024","author":"Q-Y Lu","year":"2024","unstructured":"Lu Q-Y, Guo L, Zhang Q-Y, Yang F-M, Zhou S-T, Sun Q-Y (2024) Luteolin alleviates the TNF-\u03b1-induced inflammatory response of human microvascular endothelial cells via the Akt\/MAPK\/NF-\u03baB pathway. Mediators Inflamm 2024(1):6393872","journal-title":"Mediators Inflamm"},{"key":"1846_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.813169","volume":"9","author":"B Lv","year":"2022","unstructured":"Lv B, Shen N, Cheng Z, Chen Y, Ding H, Yuan J, Zhao K, Zhang Y (2022) Strategies for biomaterial-based spinal cord injury repair via the TLR4-NF-\u03baB signaling pathway. Front Bioeng Biotechnol 9:813169","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"1846_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40164-024-00529-z","volume":"13","author":"Q Ma","year":"2024","unstructured":"Ma Q, Hao S, Hong W, Tergaonkar V, Sethi G, Tian Y, Duan C (2024) Versatile function of NF-\u0138B in inflammation and cancer. Exp Hematol Oncol 13(1):68","journal-title":"Exp Hematol Oncol"},{"key":"1846_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114406","volume":"152","author":"H-Y Ma","year":"2025","unstructured":"Ma H-Y, Wang J, Wang J, Guo Z, Qin X-Y, Lan R, Hu Y (2025) Luteolin attenuates cadmium neurotoxicity by suppressing glial inflammation and supporting neuronal survival. Int Immunopharmacol 152:114406","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1846_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ph18010104","volume":"18","author":"R Mallick","year":"2025","unstructured":"Mallick R, Basak S, Chowdhury P, Bhowmik P, Das RK, Banerjee A, Paul S, Pathak S, Duttaroy AK (2025) Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies. Pharmaceuticals 18(1):104","journal-title":"Pharmaceuticals"},{"issue":"11","key":"1846_CR54","first-page":"1","volume":"3","author":"MF Manzoor","year":"2017","unstructured":"Manzoor MF, Ahmad N, Manzoor A, Kalsoom A (2017) Food based phytochemical luteolin their derivatives, sources and medicinal benefits. Int J Agric Life Sci IJAL 3(11):1","journal-title":"Int J Agric Life Sci IJAL"},{"issue":"5","key":"1846_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-025-02685-6","volume":"42","author":"K Maparu","year":"2025","unstructured":"Maparu K, Chatterjee D, Kaur R, Kalia N, Kuwar OK, Attri M, Singh S (2025) Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implications. Med Oncol 42(5):1\u201318","journal-title":"Med Oncol"},{"key":"1846_CR56","unstructured":"Maranga CSB (2016) Early mitochondrial modifications in YAC128 transgenic model of Huntington\u2019s disease Universidade de Coimbra (Portugal)]"},{"key":"1846_CR57","unstructured":"Maryam S, Khalid S, Arshad A, Abid S, Iqbal LZ, Amjad Y, Faisal S (2024) Luteolin: a versatile flavonoid for anti-inflammatory, anti-cancer, and neuroprotective therapies"},{"issue":"9","key":"1846_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70025","volume":"30","author":"A Mohammed","year":"2024","unstructured":"Mohammed A, Ramadan A, Elnour AA, Saeed AAAM, Al Mazrouei N, Alsulami FT, Alqarni YS, Menon V, Amoodi AA, Abdalla SF (2024) Luteolin as potential treatment for Huntington\u2019s disease: Insights from a transgenic mouse model. CNS Neurosci Ther 30(9):e70025","journal-title":"CNS Neurosci Ther"},{"key":"1846_CR59","unstructured":"Mokgobu MI (2013) Investigation of the pro-oxidative and pro-inflammatory interactions of manganese with cells of the innate immune system University of Pretoria]"},{"issue":"4","key":"1846_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40291-023-00654-1","volume":"27","author":"TT Nguyen","year":"2023","unstructured":"Nguyen TT, Nguyen-Thi P-T, Nguyen THA, Ho T-T, Tran N-M-A, Van Vo T, Van Vo G (2023) Recent advancements in nanomaterials: a promising way to manage neurodegenerative disorders. Mol Diagn Ther 27(4):457\u2013473","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"1846_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","volume":"244","author":"SK Niture","year":"2010","unstructured":"Niture SK, Kaspar JW, Shen J, Jaiswal AK (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244(1):37\u201342","journal-title":"Toxicol Appl Pharmacol"},{"key":"1846_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2015.10.004","volume":"91","author":"AM Oliveira","year":"2015","unstructured":"Oliveira AM, Cardoso SM, Ribeiro M, Seixas RS, Silva AM, Rego AC (2015) Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington\u2019s disease mouse striatal cells. Neurochem Int 91:1\u201312","journal-title":"Neurochem Int"},{"key":"1846_CR63","doi-asserted-by":"publisher","first-page":"1271102","DOI":"10.3389\/fimmu.2023.1271102","volume":"14","author":"R Pandey","year":"2023","unstructured":"Pandey R, Bakay M, Hakonarson H (2023) SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Front Immunol 14:1271102","journal-title":"Front Immunol"},{"issue":"s3","key":"1846_CR64","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimer\u2019s Dis 42(s3):S125\u2013S152","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"1846_CR65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3892\/ol.2021.12452","volume":"21","author":"R Raina","year":"2021","unstructured":"Raina R, Pramodh S, Rais N, Haque S, Shafarin J, Bajbouj K, Hamad M, Hussain A (2021) Luteolin inhibits proliferation, triggers apoptosis and modulates Akt\/mTOR and MAP kinase pathways in HeLa cells. Oncol Lett 21(3):192","journal-title":"Oncol Lett"},{"issue":"8","key":"1846_CR66","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA (2004) The JAK\/STAT signaling pathway. J Cell Sci 117(8):1281\u20131283","journal-title":"J Cell Sci"},{"issue":"1","key":"1846_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-023-00380-y","volume":"12","author":"PJ Richardson","year":"2023","unstructured":"Richardson PJ, Smith DP, de Giorgio A, Snetkov X, Almond-Thynne J, Cronin S, Mead RJ, McDermott CJ, Shaw PJ (2023) Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. Trans Neurodegener 12(1):47","journal-title":"Trans Neurodegener"},{"issue":"1","key":"1846_CR68","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/ijms24010864","volume":"24","author":"M Rusek","year":"2023","unstructured":"Rusek M, Smith J, El-Khatib K, Aikins K, Czuczwar SJ, Pluta R (2023) The role of the JAK\/STAT signaling pathway in the pathogenesis of Alzheimer\u2019s disease: new potential treatment target. Int J Mol Sci 24(1):864","journal-title":"Int J Mol Sci"},{"key":"1846_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S, Buttari B, Profumo E, Tucci P, Saso L (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15:787258","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1846_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","volume":"4","author":"A Sarapultsev","year":"2023","unstructured":"Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D (2023) JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions. Mol Biomed 4(1):40","journal-title":"Mol Biomed"},{"issue":"1","key":"1846_CR71","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/nu16010102","volume":"16","author":"H Sharma","year":"2023","unstructured":"Sharma H, Sharma N, An SSA (2023) Unique bioactives from Zombie Fungus (Cordyceps) as promising multitargeted neuroprotective agents. Nutrients 16(1):102","journal-title":"Nutrients"},{"issue":"2","key":"1846_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/rej.2024.0045","volume":"28","author":"R She","year":"2025","unstructured":"She R, Zhang Z, Han M, Zhao D, Li X, Zhou J, Chang Y, Zhang X, Li X (2025) Luteolin exhibits anxiolytic and antidepressant potential in Parkinson\u2019s disease rat: antioxidant and anti-inflammatory effects. Rejuvenation Res 28(2):67\u201382","journal-title":"Rejuvenation Res"},{"key":"1846_CR73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"R-H Shih","year":"2015","unstructured":"Shih R-H, Wang C-Y, Yang C-M (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"1846_CR74","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1226","volume":"3","author":"K Shuai","year":"2003","unstructured":"Shuai K, Liu B (2003) Regulation of JAK\u2013STAT signalling in the immune system. Nat Rev Immunol 3(11):900\u2013911","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1846_CR75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1476-5586(03)80025-8","volume":"5","author":"AL Silvers","year":"2003","unstructured":"Silvers AL, Bachelor MA, Bowden GT (2003) The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression. Neoplasia 5(4):319\u2013329","journal-title":"Neoplasia"},{"issue":"7","key":"1846_CR76","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/00004647-200007000-00007","volume":"20","author":"A Simi","year":"2000","unstructured":"Simi A, Ingelman-Sundberg M, Tindberg N (2000) Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase. J Cereb Blood Flow Metab 20(7):1077\u20131088","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"1846_CR77","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918\u2013935","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"1846_CR78","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3109\/10715762.2010.507670","volume":"44","author":"S Singh","year":"2010","unstructured":"Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P (2010) Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 44(11):1267\u20131288","journal-title":"Free Radic Res"},{"issue":"3","key":"1846_CR79","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2174\/0113862073303342240409060918","volume":"28","author":"NK Singh","year":"2025","unstructured":"Singh NK, Bhushan B, Singh P, Sahu KK (2025) Therapeutic expedition of luteolin against brain-related disorders: an updated review. Comb Chem High Throughput Screen 28(3):371\u2013391","journal-title":"Comb Chem High Throughput Screen"},{"key":"1846_CR80","doi-asserted-by":"crossref","unstructured":"Singh V, Dey P (2025) Theoretical aspects of protein aggregation and neurodegenerative diseases. Neurological problems in the elderly-bridging current state and New Outlooks: Bridg Curr State New Outlooks 35","DOI":"10.5772\/intechopen.1006957"},{"issue":"2","key":"1846_CR81","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Nutma E, van der Valk P, Amor S (2018) Inflammation in CNS neurodegenerative. Dis Immunol 154(2):204\u2013219","journal-title":"Dis Immunol"},{"issue":"6","key":"1846_CR82","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/ph15060692","volume":"15","author":"S Suzen","year":"2022","unstructured":"Suzen S, Tucci P, Profumo E, Buttari B, Saso L (2022) A pivotal role of Nrf2 in neurodegenerative disorders: a new way for therapeutic strategies. Pharmaceuticals 15(6):692","journal-title":"Pharmaceuticals"},{"key":"1846_CR83","doi-asserted-by":"publisher","first-page":"122228","DOI":"10.1016\/j.lfs.2023.122228","volume":"334","author":"HX Teh","year":"2023","unstructured":"Teh HX, Phang SJ, Looi ML, Kuppusamy UR, Arumugam B (2023) Molecular pathways of NF-\u0138B and NLRP3 inflammasome as potential targets in the treatment of inflammation in diabetic wounds: A review. Life Sci 334:122228","journal-title":"Life Sci"},{"issue":"6","key":"1846_CR84","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/biomedicines10061270","volume":"10","author":"M-M Tsai","year":"2022","unstructured":"Tsai M-M, Chen J-L, Lee T-H, Liu H, Shanmugam V, Hsieh H-L (2022) Brain protective effect of resveratrol via ameliorating interleukin-1\u03b2-induced MMP-9-mediated disruption of ZO-1 arranged integrity. Biomedicines 10(6):1270","journal-title":"Biomedicines"},{"issue":"5","key":"1846_CR85","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12272-021-01332-8","volume":"44","author":"A Uprety","year":"2021","unstructured":"Uprety A, Kang Y, Kim SY (2021) Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders. Arch Pharmacal Res 44(5):487\u2013498","journal-title":"Arch Pharmacal Res"},{"issue":"13","key":"1846_CR86","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ars.2023.0234","volume":"38","author":"A Uruno","year":"2023","unstructured":"Uruno A, Yamamoto M (2023) The KEAP1-NRF2 system and neurodegenerative diseases. Antioxid Redox Signal 38(13):974\u2013988","journal-title":"Antioxid Redox Signal"},{"key":"1846_CR87","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00204-008-0345-3","volume":"82","author":"SV Verstraeten","year":"2008","unstructured":"Verstraeten SV, Aimo L, Oteiza PI (2008) Aluminium and lead: molecular mechanisms of brain toxicity. Arch Toxicol 82:789\u2013802","journal-title":"Arch Toxicol"},{"issue":"11","key":"1846_CR88","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1089\/ars.2010.3211","volume":"13","author":"NF Villeneuve","year":"2010","unstructured":"Villeneuve NF, Lau A, Zhang DD (2010) Regulation of the Nrf2\u2013Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal 13(11):1699\u20131712","journal-title":"Antioxid Redox Signal"},{"key":"1846_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.757161","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y, Wang H, Du J (2021) Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson\u2019s disease. Front Pharmacol 12:757161","journal-title":"Front Pharmacol"},{"issue":"9","key":"1846_CR90","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1002\/fsn3.2459","volume":"9","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Wang Y, Xiong Y, Teng L (2021) Protective effect of Salidroside on hypoxia-related liver oxidative stress and inflammation via Nrf2 and JAK2\/STAT3 signaling pathways. Food Sci Nutr 9(9):5060\u20135069","journal-title":"Food Sci Nutr"},{"key":"1846_CR91","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2014.03.009","volume":"71","author":"J Xu","year":"2014","unstructured":"Xu J, Wang H, Ding K, Zhang L, Wang C, Li T, Wei W, Lu X (2014) Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2\u2013ARE pathway. Free Radical Biol Med 71:186\u2013195","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"1846_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13148-025-01820-4","volume":"17","author":"Y-Q Xu","year":"2025","unstructured":"Xu Y-Q, Chen Y, Xing J-X, Yao J (2025) Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy. Clin Epigen 17(1):13","journal-title":"Clin Epigen"},{"issue":"3","key":"1846_CR93","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98(3):1169\u20131203","journal-title":"Physiol Rev"},{"key":"1846_CR94","doi-asserted-by":"crossref","unstructured":"Yan M, Sun Z, Zhang S, Yang G, Jiang X, Wang G, Li R, Wang Q, Tian X (2024) SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options. Brain Res Bull 110988","DOI":"10.1016\/j.brainresbull.2024.110988"},{"key":"1846_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.716672","volume":"12","author":"Q Yin","year":"2021","unstructured":"Yin Q, Wang L, Yu H, Chen D, Zhu W, Sun C (2021) Pharmacological effects of polyphenol phytochemicals on the JAK-STAT signaling pathway. Front Pharmacol 12:716672","journal-title":"Front Pharmacol"},{"issue":"8","key":"1846_CR96","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1515\/revneuro-2024-0040","volume":"35","author":"S Yu","year":"2024","unstructured":"Yu S, Chen X, Yang T, Cheng J, Liu E, Jiang L, Song M, Shu H, Ma Y (2024) Revealing the mechanisms of blood\u2013brain barrier in chronic neurodegenerative disease: An opportunity for therapeutic intervention. Rev Neurosci 35(8):895\u2013916","journal-title":"Rev Neurosci"},{"issue":"17","key":"1846_CR97","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms22179592","volume":"22","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci 22(17):9592","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1846_CR98","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/molecules22030334","volume":"22","author":"J-X Zhang","year":"2017","unstructured":"Zhang J-X, Xing J-G, Wang L-L, Jiang H-L, Guo S-L, Liu R (2017) Luteolin inhibits fibrillary \u03b2-Amyloid1\u201340-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-\u03baB signaling pathways. Molecules 22(3):334","journal-title":"Molecules"},{"issue":"5","key":"1846_CR99","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/ijmm.2023.5314","volume":"52","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X (2023) Inflammatory signaling pathways in the treatment of Alzheimer\u2019s disease with inhibitors, natural products and metabolites. Int J Mol Med 52(5):111","journal-title":"Int J Mol Med"},{"key":"1846_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852416","volume":"13","author":"G Zhu","year":"2022","unstructured":"Zhu G, Wang X, Chen L, Lenahan C, Fu Z, Fang Y, Yu W (2022) Crosstalk between the oxidative stress and glia cells after stroke: from mechanism to therapies. Front Immunol 13:852416","journal-title":"Front Immunol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01846-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:03:27Z","timestamp":1758085407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01846-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1846"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01846-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The authors declared that they don\u2019t have any financial or personal conflicts about this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}